2. Protein Tyrosine Kinase/RTK Neuronal Signaling
  3. VEGFR c-Kit FLT3 Discoidin Domain Receptor Trk Receptor
  4. Sitravatinib malate

Sitravatinib malate  (Synonyms: MGCD516 malate; MG-516 malate)

目录号: HY-16961A
产品使用指南

摩尔计算器

Sitravatinib malate (MGCD516 malate) 是一种有口服活性的受体酪氨酸激酶 (RTK) 抑制剂。抑制 Axl，MER，VEGFR3，VEGFR2，VEGFR1，KIT，FLT3，DDR2，DDR1，TRKA，和 TRKB，IC50 分别为 1.5 nM，2 nM，2 nM，5 nM，6 nM，6 nM，8 nM，0.5 nM，29 nM，5 nM，和 9 nM。Sitravatinib malate 单独使用即具有有效的抗肿瘤功效，且通过促进抗肿瘤免疫微环境增强了 PD-1 阻断的活性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

Sitravatinib malate Chemical Structure

Sitravatinib malate Chemical Structure

CAS No. : 2244864-88-6

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Sitravatinib malate 的其他形式现货产品:

Customer Review

Other Forms of Sitravatinib malate:

Sitravatinib malate 相关抗体

Top Publications Citing Use of Products

查看 VEGFR 亚型特异性产品:

查看所有亚型
VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4

查看 Discoidin Domain Receptor 亚型特异性产品:

查看所有亚型
DDR1 DDR2

查看 Trk Receptor 亚型特异性产品:

查看所有亚型
TrkA TrkB TrkC Trk

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Sitravatinib malate (MGCD516 malate) is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively[1]. Sitravatinib malate shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment[2].

IC50 & Target[1]

VEGFR1

6 nM (IC50)

VEGFR2

5 nM (IC50)

VEGFR3

2 nM (IC50)

TrkA

5 nM (IC50)

TrkB

9 nM (IC50)

DDR1

29 nM (IC50)

DDR2

0.5 nM (IC50)

Axl

1.5 nM (IC50)

MER

2 nM (IC50)

KIT

6 nM (IC50)

FLT3

8 nM (IC50)

体外研究
(In Vitro)

Sitravatinib (0.01 nM-10 μM; 14 days) reduces colony formation in a dose-dependent manner in KLN205 and E0771 cell lines[2].
Sitravatinib (0.001-10 μM; 5 days) inhibits tumor cell viability with IC50s of approximately 1 μM in KLN205, E0771 and CT1B-A5 cell lines[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Sitravatinib malate 相关抗体:

Cell Viability Assay[2]

Cell Line: KLN205, E0771, CT1B-A5 cells
Concentration: 0.001, 0.01, 0.1, 1, 10 μM
Incubation Time: 5 days
Result: Inhibited KLN205, E0771, CT1B-A5 cells with IC50s of approximately 1 μM.
体内研究
(In Vivo)

Sitravatinib (20 mg/kg; p.o.; once per day for 6 days) significantly inhibits tumor progression and induces tumor regression in C57BL/6 mice bearing CT1B-A5 cells model[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 6-week-old C57BL/6 mice (bearing CT1B-A5 cells)[2]
Dosage: 20 mg/kg
Administration: Oral administration; once per day for 6 days
Result: Significantly inhibited tumor progression and induced tumor regression.
Clinical Trial
分子量

763.76

Formula

C37H35F2N5O9S
CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

Sitravatinib malate 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Sitravatinib2244864-88-6MGCD516MG-516MGCD 516MGCD-516MG516MG 516VEGFRc-KitFLT3Discoidin Domain ReceptorTrk ReceptorVascular endothelial growth factor receptorSCFRCD117Cluster of differentiation antigen 135CD135Fms like tyrosine kinase 3Tropomyosin related kinase receptorRTKTyrosinekinaseCancerimmunotherapyMacrophagesimmunePD-1AxlMERVEGFR3VEGFR2VEGFR1KITDDR2DDR1TRKATRKBInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Sitravatinib malate
目录号：
HY-16961A
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z